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Abstract. When expressed in livers of transgenic
mice, the human low density lipoprotein (LDL) recep-
tor is specifically targeted to the basolateral (sinusoi-
dal) surface of hepatocytes as determined by im-
munofluorescence and immunoelectron microscopy.
The COOH-terminal cytoplasmic domain of the recep-
tor (residues 790-839) contains a signal for this tar-
geting. A mutant receptor truncated at residue 812
was localized exclusively to the apical (bile canalicu-
lar) surface. A mutant receptor terminating at residue
829 showed the normal basolateral distribution, as did
a receptor in which alanine was substituted for serine
833, which was previously shown to be a site for
T
HE low density lipoprotein (LDL)' receptor takes up
cholesterol-carrying lipoproteins by receptor-medi-
ated endocytosis in coated pits (Goldstein et al., 1985).
In cultured fibroblasts, where the process has been studied
most extensively, 60-80% of LDL receptors are located in
coated pits at all times. LDL receptors migrate to these pits,
internalize, and recycle spontaneously without a require-
ment for LDL binding. In the body the majority of LDL
receptors are found on hepatocytes where they mediate the
removal of intermediate density lipoproteins and LDL from
blood (Brown and Goldstein, 1986; Havel and Hamilton,
1988; Spady et al., 1986). To perform this function, the
receptors must be located on the basolateral (sinusoidal) sur-
faces of hepatocytes, and it is presumed that they must also
migrate to coated pits.
More than 100 different mutations in the gene for the hu-
man LDL receptor impair lipoprotein clearance in the liver
and produce the syndrome of familial hypercholesterolemia
with its attendant atherosclerosis (Hobbs et al ., 1990). Three
ofthese mutations alterthe cytoplasmic domain ofthe recep-
tor, which contains the signal that mediates clustering in
coated pits. In fibroblasts these receptors bind LDL but they
1. Abbreviations used in this paper: LDL, low density lipoprotein; p1gR,
polymeric IgA/IgM receptor.
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phosphorylation in vitro. These data localize the
basolateral targeting signal to the 17-residue segment
between residues 812 and 828. A 10-amino acid
stretch within this segment shows a 4/10 match with a
sequence within a previously identified basolateral
sorting motif for the receptor for polymeric IgA/IgM
in MDCK cells. The four shared residues are spaced
at intervals of three, raising the possibility that they all
face the same side of an a-helix .: We conclude that
this 10-amino acid stretch may contain a signal that
directs certain proteins, including the LDL receptor
and the polymeric IgG/IgM receptor, to the
basolateral surface of polarized epithelia.
cannot cluster in coated pits, and therefore they cannot carry
LDL into the cell. In the body these mutations raise plasma
LDL to the same extent as do gross deletions in the LDL
receptor gene, indicating that coated pit clustering is crucial
for the function of the LDL receptor in hepatocytes as well
as in fibroblasts (Goldstein and Brown, 1989).
Despite this circumstantial evidence for coated pit involve-
ment in LDL receptor function in liver, this conclusion has
been difficult to validate experimentally. Under normal con-
ditions the number of receptors in liver is too small to be
localized directly with immunocytochemical techniques.
When the LDL receptor is overexpressed, either as a result
of induction with 17 o-ethinyl estradiol (Havel and Hamil-
ton, 1988; Handley et al ., 1983) or by transcription from a
strong promoter in transgenic mice (Pathak et al., 1990),
most of the receptors are found in a diffuse distribution on
microvilli at the basolateral surface, and only a few are found
in coated pits. Nevertheless, these receptors mediate the
rapid uptake of LDL into hepatocytes. These findings have
led to the conclusion that the entry of LDL receptors into
coated pits in liver may be slower than occurs in fibroblasts
(Handley et al., 1983; Pathak et al., 1990). In fact, this lo-
calization might occur only in response to the binding of
LDL, in a fashion that resembles the ligand-triggered en-
docytosis of the receptor for epidermal growth factor
(Schlessinger, 1988) . If such regulation exists, it is likely to
be mediated by sequences in the cytoplasmic tail of the
39receptor, which is responsible for clustering in coated pits
(Chen et al ., 1990) .
The cytoplasmic tail of the LDL receptor comprises the
50 COON-terminal amino acids (residues 790-839) . Resi-
dues 802-807 comprise the signal for entry into coated pits,
FDNPVY (Chen et al., 1990) . Studies with nuclear mag-
netic resonance spectroscopy have shown that a synthetic
peptide containing this sequence forms a tight reverse turn
in solution (Bansal and Gierasch, 1991) . A tight turn con-
taining a tyrosine is a frequent, if not universal, signal for
entry of receptors into coated pits (Collawn et al., 1990,
1991). Truncationofthe LDL receptor at residue 812, which
leaves the internalization signal intact, does not affect the
rapid coated pit-mediated internalization of LDL receptors,
nor its recycling in fibroblasts (Davis et al., 1987; Chen et
al., 1990) . Although the COOH-terminal 28 amino acids of
the LDL receptor are dispensable for function in fibroblasts,
these residues are nearly 100% conserved in species as re-
mote as Xenopus laevis and humans (Mehta et al., 1991).
Considered together, these findings raise the possibility that
the COOH-terminal 28 amino acids might contain a signal
that regulates the distribution of the LDL receptor in pola-
rized epithelial cells such as hepatocytes.
The localization of the LDL receptor to specific surfaces
of polarized epithelia has been examined in transgenic mice
overexpressing the normal human LDL receptor (Pathak et
al., 1990)and in cultured MDCK cells(Li et al ., 1991; Hun-
ziker et al., 1991) . In the transgenic mice the LDL receptor
was present in a diffuse distribution on microvilli at the
basolateral surface of hepatocytes and intestinal epithelial
cells, but surprisingly in renal epithelial cells it was present
on the apical surface where it appeared to cluster in coated
pits and endocytic vesicles (Pathak et al., 1990). In sharp
contrast, in MDCK cellsthe wild-type LDL receptor was lo-
cated primarily on the basolateral surface (Li et al., 1991;
Hunziker et al ., 1991) . Elimination of the tyrosine internali-
zation signal prevented rapid internalization of the receptor
in MDCK cells, but it did not alter its location on the
basolateral surface. However, when the receptor was trun-
cated so as to eliminate the cytoplasmic tail, most of the
receptors were found at the apical surface (Hunziker et al. ,
1991) . These results were interpreted to indicate that the cy-
toplasmic tail contains a signal, separate from the tyrosine
internalization signal, that directs it to the basolateral surface
of MDCK cells.
As yet, there are no reliable experimental systems to study
polarized expression ofproteins in cultured hepatocytes. Ac-
cordingly, in the current studies we have compared the cellu-
lar distribution of normal and mutant human LDL receptors
in livers oftransgenic mice. The results suggest that the cyto-
plasmic tail of the receptor contains a signal for basolateral
sorting in hepatocytes and that this signal is located between
residues 812 and 828.
Materials and Methods
Materials
All reagents and chemicals used for immunofluorescence and immunogold
labeling were obtained from previously described sources (Pathak et al.,
1990; Pathakand Anderson, 1991). Weobtained rabbit anti-mouse IgG and
goat anti-rabbit IgG labeled with FITC from Zymed Laboratories (San
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Francisco, CA); sheepanti-rabbitIgG from Organon Teknika-Cappel (Mal-
vern, PA); monoclonal mouse anti-dinitrophenol IgGfromOxfordBiomed-
ical (Oxford, MI); and goat anti-rabbit IgG conjugated togold (10nm) from
Energy Sciences (Woburn, MA). A polyclonal rabbit IgG directed against
the LDL receptor was prepared by immunizing a New Zealand white rabbit
with purified bovine LDL receptor as previously described (Russell et al.,
1984). A preimmune rabbit IgG was also prepared from the same rabbit.
Construction ofMetallothionein Promoter-mutant
LDL Receptor Minigenes
An expression plasmid containing the mouse metallothionein-I promoter
fused to a human LDL receptorminigene(designated transgene 2) was con-
structed as previously described (Pathak et al., 1990). This wild-type trans-
gene was modified by oligonucleotide-directed mutagenesis (Zoller and
Smith, 1984) to create three mutant versions of the LDL receptor: one con-
tained a termination codon at amino acid residue 812 (designated transgene
4); the second contained a termination codon at residue 829 (designated
transgene 5); and the third contained a single amino acid substitution (Ser
-~ Ala) at residue 833 (designated transgene 6).
To engineer LDL receptor transgene 4 (hereafter designated Stop 812
receptor), a single-strandedM13 DNA template containing a 2.4-kbEcoRl-
Smal fragment from pLDLR-2 (Yamamoto et al., 1984) was hybridized
with a mutagenic 27-mer oligonucleotide. After hybridization, primer ex-
tension, and ligation, the DNA was transformed into Eschedchia coli TGl
cells. Clones carrying thedesired mutationwere identified by hybridization
and sequencing as described by Davis et al. (1987). A 1.1 kb Bg1II-SmaI
fragmentencoding the membrane-spanningand cytoplasmicdomains ofthe
mutated LDL receptor was excised from the replicative form of M13 DNA
and then subcloned into pSLH16, a plasmid that harbors LDL receptor
transgene 2 (Pathak et al., 1990). To create LDLreceptor transgene 5 (Stop
829 receptor) and transgene 6 (Ala 833 receptor), a 1.1-kb BglH-SmaI frag-
ment that encodes the same domains of the LDL receptor as described for
LDL receptor transgene 4 was excised from pLDLR4 Stop 829 and
pLDLR4 Ala 833, two previously described plasmids encoding mutant
receptors (Davis et al., 1987), and subcloned into pSLH16.
Themutated region of each reconstructed plasmid was sequenced by the
method of Sanger et al. (1977), and the plasmids were checked for expres-
sion by transient tránsfection into hamster íd1.47 cells using a modified cal-
cium phosphate precipitation method (Davis et al ., 1986). The length of
LDL receptor transgenes 4, 5, and 6 was -14.7 kb. Nod sites at the 5' and
3' ends of the transgenes were used to excise the DNA from the plasmid
vector before microinjection into fertilized mouse eggs.
Transgenic Mice
A total of 909 eggs were microinjected with the Stop 812 transgene and
transferred into pseudopregnant females (Brinster et al., 1985). Among 99
offspring, 24 (24%) containedthetransgeneas determinedby dot hybridiza-
tion ofDNAobtainedfromtail homogenates(Hofmann et al., 1988). These
founder mice were treated with 25 mM ZnSO4 in the drinking water for
7-d to induce the metallothionein promoter(Palmiter etal. 1983), andthree
mice were shown to overexpress the transgene-derived mutant LDL recep-
tor in the liver as determined after partial hepatectomy and immunoblot
analysis (see below). These mice were bred to C57Bl/6J x SJL Fl mice
to establish three lines of Stop 812 mice (321-4, 340-1, and 343-2).
A total of 555 eggs were microinjected with the Stop 829 transgene and
transferred to recipients. A total of 45 offspring was obtained, seven of
which (16%) contained the transgene. After treatment with 25 mM ZnSO4
in drinking water for 7 d, three mice were shown to express the transgene-
derived mutant LDL receptor in the liver as determined by immunoblot
analysis. Two ofthese mice were bred to C57B1/6J x SJL Fl mice to estab-
lish one line of Stop 829 mice (403-1). The second male mouse (399-5),
which expressed at the highest level, was infertile, and therefore we could
not establish a line.
A total of 579 eggs were microinjected with the Ala 833 transgene and
transferred to recipients. Of 56 offspring obtained, 26 (46%) contained the
transgene. After treatment with 25 mM ZnSO4 in the drinking water for
7 d, 11 mice were shown to express the transgene-derived mutant LDL
receptor in the liver as determined by immunoblot analysis. These mice
were bred to C57B1/6J x SJL Fl mice, and one line of the Ala 833 mice
(369-2) was established.
Two lines oftransgenic mice (192-2 and 188-1) that express transgene 2
encoding the metallothionein-driven wild-type human LDL receptor
minigene were established as previously reported (Pathak et al., 1990).
40Where indicated in the figure legends, mice were treated either with
ZnSO4 (25 mM) in the drinking water for 7 to 10 d or with CdS04 (1 mg/
kg) intraperitoneally 18 and 6 h before the experiment.
ImmunofluorescenceMicroscopy
Tissues obtained from perfusion-fixed mice (Pathak et al ., 1990) were
refixed for 2 d in a fixative that contained 10% (vol/vol) glacial acetic acid,
30% (vol/vol) 1,1,1-trichloroethane, and 60% (vol/vol) absolute methanol,
dehydrated in ethanol, embedded in paraffin, and sectioned (10-/Am thick-
ness) with a steel knife. Sections were mounted on glass slides, and the
paraffin was removedby incubating slides in xylene, followedby rehydration
through a descending series of ethanol . Sections were sequentially in-
cubatedat room temperatureas follows : (a) bufferA (20mM [vol/vol] Tris-
HCL at pH 9.0, 200 mM NaCl, 0.2% [wt/vol] BSA, and 0.01% [vol/vol]
NaN3) for 30 min ; (b) either 50 Feg/ml anti-LDL receptor IgG or 0.1 mg/ml
preimmune IgG in buffer A overnight; (c) 25 Ftg/ml FITC-labeled goat
anti-rabbit IgG in buffer A for 2 h . Each incubation was followed by three
successive 5 min washes in bufferA . Finally, sections were rinsed in dis-
tilled water for 2 min and mounted inDABCO (90% [vol/vol] glycerol, 50
mM Tris-HCL at pH 9.0, 25% [wt/vol] 1, 4-diazadicyclo-[2 .2.2]-octane) .
The samples were viewed and photographed with a Zeiss photomicroscope
III using eithera63 or25 neofluar oil immersion objective and the appropri-
ate filter package for fluorescein .
Immunoelectron Microscopy
Liver samples from perfusion-fixed mice were dissected and kept overnight
in the perfusion fixative . Vibratome sections (60-80-Fern thick) were pre-
pared and washed in 100mM sodium phosphate buffer atpH 7.8 containing
50 mM ammonium chloride for 30 min and then transferred to buffer B
(buffer A containing 0.05% [wt/vol] saponin) for 1 h . The primary antibod-
ies, rabbit anti-LDL receptor IgG and the preimmune IgG, were diluted in
bufferB to a final concentration of50 lAg/ml . Groups ofsix to eight sections
were incubated overnight with each of the antibodies . This was followed by
a 3-h incubation with 20 leg/ml of sheep anti-rabbit IgG conjugated with
dinitrophenol in buffer B (Pathak and Anderson, 1989) . After each incuba-
tion sections were washed three times for 5 min each in buffer B. After a
final wash, sections were rinsed twice in 100mM sodium phosphate buffer
(pH 7.8) and fixed with 1.33% (vol/vol) glutaraldehyde for 2 h in the same
buffer. Tissue sections were postfixed with 1% (vol/vol) osmium tetroxide
in phosphate buffer, dehydrated, embedded in Epon, sectioned, and
processed to localize dinitrophenol groups by immunogold labeling using
mouse anti-dinitrophenol IgG followed by rabbit anti-mouse IgG and goat
anti-rabbit IgG conjugated to gold (10 nm) (Pathak and Anderson, 1991) .
ImmunoblotAnalysis
Mouse liver membranes were prepared and subjected to immunoblot analy-
sis as described by Pathak et al . (1990) . The extracts (125 to 250 gg of pro-
tein per lane) were subjected to 7% SDS-PAGE under either reducing or
nonreducing conditions (with or without 10% [vol/vol] 2-mercaptoethanol)
and transferred to nitrocellulose filters . After transfer the filters were in-
cubated with 51tg/nil ofpolyclonal rabbit anti-LDL receptor IgG followed
by 1211-labeled goat anti-rabbit IgG (5 x 106 cpm/ml) and then subjected
to autoradiography .
Lipoprotein Turnover Studies
Transgenic mice (22-27-g body weight) were treated with CdS04 (1 mg/
kg) intraperitoneally 18 and 6 h before the experiment . After anesthesia
with sodium pentobarbital (90 mg/kg), each mouse received an intravenous
bolus via the external jugular vein of 0.1 ml of 150 mM NaCl containing
BSA (2 mg/ml) and 15 Ftg of 12sí-labeled human LDL (600 cpm/ng pro-
tein) (Goldstein et al ., 1983) . Blood was collected by retro-orbital puncture
and placed in EDTA-coated tubes at the times indicated, and a portion of
the plasma (10 Fel) was counted for its 'z5 í content. The amount of izsI-
labeled LDL remaining in the circulation was calculated as the percent of
control . The "100% of control" value represents the mean value for
1251-
radioactivity present in the plasma of four nontransgenic normal mice at
1 min after injection with the same preparation of 125I-LDL.
Results
Fig . 1 shows the amino acid sequence of the cytoplasmic tail
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Figure 1 . Amino acid sequence of the cytoplasmic domain of the
humanLDL receptor. The signal forcoatedpit localization is boxed
(residues 802-807) . The four LDL receptor transgenes used in the
current study are designated in the text as follows : wild-type recep-
tor (transgene 2), Stop 812 receptor (transgene 4), Stop 829 recep-
tor (transgene 5), and Ala 833 receptor (transgene 6) .
of the human LDL receptor and indicates the position of the
FDNPVY internalization signal as well as the three muta-
tions that were studied in the current paper. Stop 812 and
Stop 829 are premature termination codons. Ala 833 con-
tains an alanine in place of a serine at a site near the COOH
terminus that was previously shown to be phosphorylated in
vitro by a casein kinase II-like enzyme isolated from adrenal
cortex (Kishimoto et al ., 1987) . All of these mutations were
created by in vitro mutagenesis techniques in a plasmid that
contains a minigene comprising the entire coding region of
the human LDL receptor as well as several introns near the
Figure 2 . Immunoblot analysis of human LDL receptors in livers
of transgenic mice . Transgenic mice were treated with CdS04 as
described in Materials and Methods, after which aliquots of the
100,000 g membrane fraction from liver were subjected to 7
SDS-PAGE under either nonreducing (lanes 1 to 4) or reducing
(lanes S to 8) conditions and transferred to nitrocellulose filters .
The filters were immunoblotted with a rabbit anti-LDL receptor
IgG, probed with 1251-labeled goat anti-rabbit IgG, and exposed to
XAR-5 film with an intensifying screen at -70°C for either 6 h
(lanes 1 to 4) or 24 h (lanes S to 8) . (Lanes 1, 4, 5, and 8) Mem-
branes froma mouse expressing the wild-type receptor (125 Ag pro-
tein per lane) ; (lanes 2 and 6) membranes from a mouse expressing
the Stop 829 truncation (205 lAg protein per lane) ; (lanes 3 and 7)
membranes from a mouse expressing the Stop 812 truncation (250
wg protein per lane) .Figure 3. Immunofluorescence localization of humanLDL receptors in liver from transgenic mice expressing either the wild-type receptor
(A) or Stop 812 receptor (B) . Mice were treated with ZnSO4 , after which liver samples were processed for immunofluorescence as de-
scribed in Materials and Methods . (B) Arrows denote canaliculi that are stained with the anti-LDL receptor IgG . Bar, 10 pm .
5' end (see Fig . 1 in Pathak et al ., 1990) . The promoter was
derived from the mouse metallothionein-I gene, and all mice
were treated with either zinc or cadmium to induce maximal
expression of the receptor .
Fig . 2 shows immunoblots of the wild-type, Stop 829, and
Stop 812 human LDL receptors after SDS gel electrophore-
sis ofcrudemembrane pellets from livers of transgenic mice .
All three receptors were expressed at high levels after heavy
metal induction, and all three showed the expected sizes after
electrophoresis under nonreducing or reducing conditions .
As reported previously, the wild-type human LDL recep-
tor was confined to the basolateral surface of hepatocytes as
revealed by immunofluorescence studies (Fig . 3 A) . In strik-
ing contrast, the Stop 812 receptor was located exclusively
at the bile canalicular (apical) surface (Fig . 3 B) . Distribu-
tions similar to those in Fig . 3 were observed by im-
munofluorescence in livers from eight transgenic mice from
two separate mouse lines expressing the wild-type receptor
and from 16 transgenic mice from 2 separate lines express-
ing the Stop 812 receptor.
Immunoelectron microscopy using gold-labeling tech-
niques confirmed that the Stop 812 receptor was located at
the apical surface of hepatocytes (Fig . 4 A) . When examined
by higher power, the mutant receptors were observed to be
in a diffuse distribution on microvilli of the apical surface
with no apparent concentration in coated pits (Fig . 4 B) . In
contrast, the wild-type human LDL receptor was found ex-
clusively at the basolateral surface of hepatocytes in the
transgenic mice, and again there was no tendency for con-
centration in coated pits (Fig . 4 C) . Fig . 4D shows a control
experiment from a nontransgenic mouse showing that the an-
tibody does not detect the mouse receptor.
As would be expected from its apical distribution, the Stop
812 receptor was unable to mediate the rapid clearance of
LDL from plasma . Fig . 5 shows an experiment in which
we injected 'III-labeled LDL intravenously into transgenic
Figure 4. Immunogold localization ofLDL receptors in hepatocytes from a nontransgenic normal mouse (D) and from transgenic mice
that express either the wild-type receptor (C) or the Stop 812 receptor (A and B) . All animals were treated with ZnS04 , after which liver
samples were prepared for immunogold labeling as described in Materials and Methods . (A) Low magnification view of hepatocytes : bl,
basolateral surface that lines the sinusoidal space; ap, apical surface that lines the canalicular space; arrowheads denote microvilli that
are labeled with anti-LDL receptor IgG-gold . (B) High magnification view of the apical surface : ap, apical surface and canalicular space ;
arrows denote clathrin-coated pits that are devoid of immunogold labeling . (C) Low magnification view of hepatocytes : bl, basolateral
surface ; arrows denote clathrin-coated pits ; arrowheads denote microvilli ; ap, apical surface . (D) Low-magnification view of hepatocytes
from a nontransgenic mouse ; bl, basolateral surface ; ap, apical surface . Bar, 0 .5 pm .
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Figure 5. Removal of 12Sí-LDL from plasma in transgenic mice .
Nonfasted transgenic mice expressing the wild-type (0) or Stop
812 (*) versions of the human LDL receptor were treated with
CdS04 and then injected intravenously with 15 wg of 125I-LDL
(600 cpm/ng protein) as described in Materials and Methods. At
the indicated time, blood was collected, and the plasma content of
1251 was measured as described in Materials and Methods . Each
value represents an individual animal.
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Figure 7 . Alignment of cytoplasmic domain sequences implicated
in basolateral sorting of the LDL receptor and the polymeric
IgA/IgM receptor. LDL receptor (LDLR) sequences from Mehta
et al . (1991) . Rabbit polymeric IgA/IgM receptor (poly IgR) se-
quence from Mostov et al . (1984) .
mice and measured the radioactivity remaining in blood af-
ter varying intervals up to 30 min . In agreement with previ-
ous observations (Hofmann et al ., 1988), transgenic mice
expressing the wild-type human LDL receptor cleared LDL
rapidly from the circulation with a half-time of less than
5 min . In contrast, the animals expressing the Stop 812 re-
ceptor showed no tendency for accelerated clearance ofLDL.
The rate ofclearance was similar to the rate observed in non-
transgenic mice studied previously (Hofmann et al ., 1988) .
Figure 6. Immunofluorescence localization ofhuman LDL receptors in livers of transgenic mice expressing either the Stop 829 receptor
(A) or the Ala 833 receptor (B) . Mice were treated with ZnSO4 , after which liver samples were processed for immunofluorescence as
described in Materials and Methods . Results similar to these were obtained in a total of two mice that express the stop 829 receptor (one
established line and one founder), and from 11 mice expressing the Ala 833 receptor (one established line and 10 founders) . Bar, 10pm .The results with the Stop 812 mutation suggest that the
LDL receptor contains a signal distal to residue 812 that is
responsible for retention on the basolateral surface of hepa-
tocytes. In an initial attempt to localize this signal, we stud-
ied two additional mutant receptors in transgenic mice. One
ofthese receptors contains an alanine substituted for a serine
at residue 833. This serine was previously shown to be a site
of phosphorylation by an enzyme resembling casein kinase-
II that was isolated from adrenal cortex and shown to phos-
phorylate the LDL receptor with extremely high affinity
(Kishimoto et al ., 1987). By immunofluorescence the Ala
833 receptor showed the same basolateral distribution as did
the wild-type receptor (Fig. 6 B). The same normal distribu-
tion was also observed for a receptor that was terminated
prematurely at position 829 (Fig. 6 A), which eliminates the
last coding exon of the LDL receptor gene (Sildhof et al.,
1985) . Although the amino acid sequence encoded by this
exon is essentially 100% conserved in humans versus Xeno-
pus laevis (Mehta et al., 1991), elimination of this exon did
not affect the steady-state distribution of LDL receptors in
livers of transgenic mice. This result suggests that the impor-
tant signal for basolateral localization resides between resi-
dues 812 and 828.
Discussion
The current data suggest that residues 812-828 of the cyto-
plasmic tail of the LDL receptor contain a signal that causes
the receptor to be localized to the basolateral surface of he-
patocytes in vivo. This conclusion is suggested by the obser-
vation that truncationofthe receptor atposition 812 redirects
the receptor to the apical surface, whereas truncation atposi-
tion 829 allows the receptor to remain in its normal location
at the basolateral surface.
The mechanisms that direct proteins to the apical or
basolateral surfaces of hepatocytes are unknown, but they
appear to differ from the mechanisms in cultured MDCK
cells. Using pulse-chase labeling and cell fractionation tech-
niques in livers of intact rats, Bartles et al. (1987) provided
evidence that proteins destined for the apical surface travel
first to the basolateral surface, and only later are transported
apically, presumably as a result of transcytosis. In MDCK
cells, which have been studied extensively in vitro, proteins
appear to be directed primarily to the apical or basolateral
surfaces, apparently as a result of sorting in the trans-Golgi
network (Simons and Wandinger-Ness, 1990; Bomsel and
Mostov, 1991).
Although basolateral targeting in MDCK cells was for-
merly considered to be a nonspecific "default" pathway, this
view has been challenged recently. Casanova et al. (1991)
identified a 14-residue segment of the cytoplasmic domain
of the polymeric IgA/IgM receptor (pIgR) whose deletion
specifically redirects the receptor to the apical surface. When
this segment was transferred to alkaline phosphatase, a pro-
tein that is normally targeted apically, the protein became
basolateral. Hunziker et al. (1991) showed that deletion of
the entire cytoplasmic domain of the LDL receptor caused
it to be restricted to the apical surface of MDCK cells, a
finding that also suggests the presence of a specific baso-
lateral targeting signal in the cytoplasmic domain of this
receptor.
A 10-amino acid segment between residues 812 and 828
of the LDL receptor resembles 10 residues in the 14-residue
sequence implicated in the basolateral sorting of the pIgR in
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MDCK cells. Fig. 7 shows the sequence of the cytoplasmic
tail of the LDL receptor in six animal species, including the
two Xenopusgene products. The sequence ofthe 812-828 re-
gion is compared with the basolateral sorting sequence in the
pIgR. Within a 10-residue segment, there is a series of iden-
ticalamino acids spaced at intervals ofthree. This shared se-
quence (RNxDxxS/TxxS) is shown in Fig. 7 with the posi-
tions numbered 1-10. It is interesting that the sequences of
the various LDL receptors match the sequence of the pIgR
at position 1 or 2, but not both. All of the LDL receptors
except the human contain an Arg at position 1, which
matches the sequence of the pIgR. These receptors all con-
tain a Ser instead of Asn at position 2. The human LDL
receptor contains a His instead of an Arg at position l, but
restores the match with the pIgR by containing an Asn at po-
sition 2. Thus, all sequences match at positions 1 or 2, 4,
7, and 10 (allowing the interchangeability of Ser and Thr),
ie., all show a four out of 10 match in this region. The regular
spacing ofthe matching residues at intervals ofthree suggests
that they might all face the same side ofan a-helix. Although
the sequences include glycine and proline residues, which
are often helix breakers, one cannot rule out a helix from pri-
mary sequence alone.
The similarity in these two sequences implies that pola-
rized epithelial cells contain a traffic-directing protein that
binds to the conserved residues and thereby directs the
receptors to the basolateral surface of the cells. Surprisingly,
the recognition sequence appears to be the same in hepato-
cytes and MDCK cells, even though previous data, reviewed
above, suggests that the mechanism for sorting differs in
these two cell types.
Casanova et al. (1990) showed that the serine at position
7 ofthe targeting sequence in the pIgR is phosphorylated and
that this negative charge is necessary for the receptor to un-
dergotranscytosis from the basolateral to the apical surface,
a normal event in the transcellular transport of the polymeric
IgA ligand. When this serine was changed to an alanine, the
pIgR continued to be targeted to the basolateral surface of
MDCK cells, but it no longer underwent transcytosis.
Rather, it appeared to recycle back to the basolateral surface.
On the other hand, when this serine was replaced with a
negatively charged aspartic acid, it underwent transcytosis
normally. These data would suggest that the conserved ser-
ine at position 7 is not essential for basolateral targeting of
the pIgR, but rather it plays a role in transcytosis. If the cor-
responding serine in the LDL receptor were to be phos-
phorylated, it might allow the receptor to transport LDL
across the cell to the biliary surface. Evidence for a low level
of such transport has been obtained (Kleinherenbrink-Stns
et al., 1990).
A cell surface endocytic receptor that shares structural and
functional features with the LDL receptor is the LDL
receptor-related protein (LRP)/cxz-macroglobulin receptor.
The external domain of this receptor resembles a four-fold
replicated LDL receptor (Herz et al., 1988; Brown et al .,
1991) . The cytoplasmic domain has 100 amino acids (twice
the size of that of the LDL receptor) that includes two copies
of a putative internalization sequence (FTNPVY and IGN-
PTY), but little other sequence identity with the LDL recep-
tor. The T in the former sequence is the final T in the se-
quence DKP_TNF_T, which resembles residues 4-10 of the
putative basolateral sorting sequence. The functional sig-
nificance ofthis similarity, if any, remains to be determined.
Preliminary analysis ofthe sequence of several other pro-
45teins known to be targeted to the basolateral surface of
MDCK cells did not reveal any sequences that resemble the
postulated targeting sequence shown in Fig. 7. The proteins
examined included the G protein of vesicular stomatitis vi-
rus, the Fc receptor, and the transferrin receptor. These pro-
teins might have basolateral sorting signals that are similar
in three-dimensional structure but not in primary sequence.
A precedent for this type ofrecognition has been established
for the sorting mechanism that directs receptors to coated
pits. An adaptor protein in coated vesicles (Glickman et al. ,
1989) recognizes tyrosine residues in the context of a tight
turn, a shape that can be achieved by many different primary
sequences (Bansal and Gierasch, 1991; Collawn et al., 1990,
1991).
An important unresolved question in the present study is
whether the Stop 812 receptor is targeted directly to the api-
cal surface of hepatocytes or whether it must first reach the
basolateral surface and then migrate to the apical surface by
transcytosis according to the pathway described by Bartles
et al. (1987). One way to test this hypothesis is to produce
a Stop 812 receptor that lacks the tyrosine signal for coated
pit internalization. If the coated pit pathway is required for
transcytosis, such a receptor would be expected to remain
on the basolateral surface.
This work was supported by research funds from the National Institutes of
Health (HL 20948), the Perot Family Foundation, and the Moss Heart
Fund.
Received for publication 6 December 1991 .
References
Bansal, A., and L. M. Gierasch. 1991 . The NPXY internalization signal of the
LDL receptor adopts a reverse turn conformation. Cell. 67:1195-1201.
Battles, J. R., H. M. Ferracci, B. Stieger, andA. L. Hubbard. 1987. Biogenesis
of the rat hepatocyte plasma membrane in vivo: comparison of the pathways
taken by apical and basolateral proteins using subcellular fractionation. J.
Cell Biol. 105:1241-1251 .
Bomsel, M., and K. Mostov. 1991 . Sorting of plasma membrane proteins in
epithelial cells. Curr. Opin. Cell Biol. 3:647-653.
Brinster, R. L., H . Y. Chen, M. E. Trumbauer, M. K. Yagle, and R. D.
Palmiter. 1985 . Factors affecting the efficiency ofintroducing foreign DNA
into mice by microinjecting eggs. Proc. Nad. Acad. Sci. USA. 82:4438-
4442.
Brown, M. S., and J. L. Goldstein. 1986. A receptor-mediatedpathway for cho-
lesterol homeostasis. Science (Wash. DC). 232:34-47.
Brown, M. S., J. Herz, R. C. Kowal, and J. L. Goldstein. 1991. The low-
density lipoprotein receptor-related protein: double agent or decoy? Curr.
Opin. Lipidology 2:65-72.
Casanova, J. E., P. P. Breitfeld, S. A. Ross, and K. E. Mostov. 1990. Phos-
phorylation of the polymeric immunoglobulin receptor required for its
efficient transcytosis. Science (Wash. DC). 248:742-746.
Casanova, J. E., G. Apodaca, and K. E. Mostov. 1991 . An autonomous signal
forbasolateral sorting in the cytoplasmic domain of the polymeric immuno-
globulin receptor. Cell. 66:65-75 .
Chen, W.-J., J. L. Goldstein, andM. S. Brown. 1990. NPXY, a sequence often
found in cytoplasmic tails, is required for coated pit-mediated internalization
of the low density lipoprotein receptor. J. Biol. Chem. 265:3116-3123.
Collawn, J. F., M. Stangel, L. A. Kuhn, V. Esekogwu, S. Jing, I. S. Trow-
bridge, andJ. A. Tainer. 1990. Transferrinreceptor internalization sequence
YXRF implicates a tight turn as the structural recognition motiffor endocy-
tosis. Cell. 63:1061-1072.
Collawn, J. F., L. A. Kuhn, L-f. Sue-Liu, J. A. Tainer, and I. S. Trowbridge.
1991. Transplanted LDL and mannose-6-phosphate receptor internalization
signals promote high-efficiency endocytosis of the transferrin receptor.
EMBO (Eur. Mol. Biol. Organ.) J. 10:3247-3253.
Davis, C. G., M. A. Lehrman, D. W. Russell, R. G. W. Anderson, M. S.
Brown, and J. L. Goldstein. 1986. The J. D. mutation in familial hyper-
cholesterolemia: amino acid substitution in cytoplasmic domain impedes in-
ternalization of LDL receptors. Cell. 45:15-24.
Davis, C. G., I. R. van Driel, D. W. Russell, M. S. Brown, and J . L. Goldstein.
1987. The LDL receptor: identification of amino acids in cytoplasmic do-
main required for rapid endocytosis. J. Biol. Chem. 262 :4075-4082.
Glickman, J. N., E. Conibear, and B. M. F. Pearse. 1989. Specificity ofbind-
ing of clathrin adaptors to signals on the mannose-6-phosphate/insulin-like
The Journal of Cell Biology, Volume 117, 1992
growth factor II receptor. EMBO (Eur. Mol. Biol. Organ.) J. 8:1041-1047.
Goldstein, J. L., and M. S. Brown. 1989. Familia l hypercholesterolemia. In
The Metabolic Basis of Inherited Disease. C. R. Scriver, A. L. Beaudet,
W. S . Sly, and D. Valle, editors. McGraw-Hill Publishing Co., New York.
1215-1250.
Goldstein, J. L., S. K. Basu, and M. S. Brown. 1983. Receptor-mediated en-
docytosis of LDL in cultured cells. Methods Enzymol. 98:241-260.
Goldstein, J. L., M . S. Brown, R. G. W. Anderson, D. W. Russell, and W. J.
Schneider. 1985 . Receptor-mediated endocytosis: concepts emerging from
the LDL receptor system. Annu. Rev. Cell Biol. 1:1-39.
Handley, D. A., C. M. Arbeeny, and S . Chien. 1983. Sinusoidal endothelial
endocytosis oflow density lipoprotein-gold conjugates in perfused livers of
ethinyl-estradiol treated rats. Eur. J. Cell Biol. 30:266-271.
Havel, R. J., and R. L. Hamilton. 1988. Hepatocytic lipoprotein receptors and
intracellular lipoprotein catabolism. Hepatology. 8:1689-1704.
Herz, J., U. Hamann, S. Rogne, O . Myklebost, H. Gausepohl, andK. K. Stan-
ley. 1988. Surface location and high affinity for calcium of a 500-kd liver
membrane protein closely related to the LDL-receptor suggest aphysiologi-
cal role as lipoprotein receptor. EMBO (Eur. Mol. Biol. Organ.) J.
7:4119-4127.
Hobbs, H. H., D. W. Russell, M. S. Brown, and J. L. Goldstein. 1990. The
LDL receptor locus and familial hypercholesterolemia: mutational analysis
of a membrane protein. Anna. Rev. Genet. 24:133-170.
Hofmann, S. L., D. W. Russell, M. S. Brown, J. L. Goldstein, and R. E. Ham-
mer. 1988. Overexpression of low density lipoprotein (LDL) receptor
eliminates LDL from plasma in transgenic mice. Science (Wash. DC).
239:1277-1281 .
Hunziker, W., C . Harter, K. Matter, and I. Mellman. 1991. Basolateral sorting
in MDCK cells requires a distinct cytoplasmic domain determinant. Cell.
66:907-920.
Kishimoto, A., M. S . Brown, C. A. Slaughter, andJ. L. Goldstein. 1987. Phos-
phorylation of serine 833 in cytoplasmic domain of LDL receptor by a high
molecular weight enzyme resembling casein kinase II. J. Biol. Chem.
262:1344-1351 .
Kleinherenbrink-Stins, M . F ., J. van der Boom, H. F. Bakkeren, P. J. M. Ro-
holl, A. Brouwer, Th. J . C. van Berkel, and D. L. Knook. 1990. Light- and
immunoelectron microscopic visualization of in vivo endocytosis oflow den-
sity lipoprotein by hepatocytes and Kupffer cells in rat liver. Lab. Invest.
64:73-86.
Li, C., S. Stifani, W. J. Schneider, and M. J. Poznansky. 1991. Low density
lipoprotein receptors on epithelial cell (Madin-Darby canine kidney)
monolayers. J. Biol. Chem. 266:9263-9270.
Mehta, K. D., W-J . Chen, J. L. Goldstein, and M. S. Brown. 1991 . The low
density lipoprotein receptor inXenopus laevis: I. Five domains that resemble
the human receptor. J. Biol. Chem. 266:10406-10414.
Mostov, K. E., M. Friedlander, and G. Blobel. 1984. The receptor for trans-
epithelial transport of IgA and IgM contains multiple immunoglobulin-like
domains. Nature (Lond.). 308 :37-43.
Palmiter, R. D., G. Norstedt, R. E. Gelinas, R. E. Hammer, and R. L. Brinster.
1983 . Metallothionein-huma n GH fusion genes stimulate growth of mice.
Science (Wash. DC). 222:809-814.
Pathak, R. K., and R. G. W. Anderson. 1989. Use of dinitrophenol-IgG con-
jugates to detect sparse antigens by immunogold labeling. J. Histochem.
Cytochem. 37:69-74.
Pathak, R. K., and R. G. W. Anderson. 1991. Use of dinitrophenol IgG con-
jugates: immunogold labeling of cellular antigens on thin sections of osmi-
cated and epon-embedded specimens. In Colloidal Gold: Principles,
Methods, and Applications. M. A. Hayat, editor. Academic Press, Inc.,
New York. 223-241.
Pathak, R. K., M. Yokode, R. E. Hammer, S. L. Hofmann, M. S. Brown, J. L.
Goldstein, and R. G. W. Anderson. 1990. Tissue-specific sorting of the hu-
man LDL receptor in polarized epithelia of transgenic mice. J. Cell Biol.
111 :347-359.
Russell, D. W., W. J. Schneider, T. Yamamoto, K. L. Luskey, M. S. Brown,
and J . L. Goldstein. 1984. Domain map of the LDL receptor: sequence ho-
mology with the epidermal growth factor precursor. Cell. 37:577-585.
Sanger, F., S. Nicklen, and A. R. Coulson. 1977. DNA sequencing with chain-
terminating inhibitors. Proc. Natl. Acad. Sci. USA. 74:5463-5467.
Schlessinger, J. 1988. The epidermal growth factor receptor as a multifunc-
tional allosteric protein. Biochemistry. 27:3119-3123 .
Simons, K., and A . Wandinger-Ness. 1990. Polarized sorting in epithelia. Cell.
62:207-210.
Spady, D. K., J. B. Meddings, and J. M. Dietschy. 1986. Kinetic constants for
receptor-dependent and receptor-independent low density lipoprotein trans-
port in the tissues of the rat and hamster. J. Clin. Invest. 77:1474-1481 .
Südhof, T. C., J. L. Goldstein, M. S . Brown, and D: W. Russell. 1985. The
LDL receptorgene: a mosaic ofexons sharedwithdifferent proteins. Science
(Wash. DC). 228:815-822.
Yamamoto, T., C. G. Davis, M. S. Brown, W. J. Schneider, M. L. Casey,
J. L. Goldstein, and D. W. Russell. 1984. The human LDL receptor: a
cysteine-rich protein with multiple Alu sequences in its mRNA . Cell.
39:27-38.
Zoller, M. J., and M. Smith. 1984. Oligonucleotide-directed mutagenesis: a
simple methodusing two oligonucleotide primers and a single-stranded DNA
template. DNA. 3:479-488 .
46